Results 171 to 180 of about 23,127 (334)

Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications [PDF]

, 2015

core   +1 more source

The use of incretins and fractures – a meta‐analysis on population‐based real life data

British Journal of Clinical Pharmacology, 2017
J. Driessen, F. de Vries, H. V. van Onzenoort, N. Harvey, C. Neef, J. V. D. van den Bergh, P. Vestergaard, R. Henry   +7 more
semanticscholar   +1 more source

GLP‐1, GIP, and Glucagon Excursions During a Mixed Meal Tolerance Test in Young and Lean South Asians Versus Europids

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 5078-5090, June 2026.
ABSTRACT Aims South Asians exhibit an unfavourable metabolic phenotype characterized by visceral obesity, insulin resistance and dyslipidemia. While various hormones play a critical role in regulating postprandial energy metabolism, it remains unclear whether they respond differently to food intake.
Carlijn A. Hoekx, Lisa B. D. Brinkman, Robin van Eenige, Sander Kooijman, Marcel H. A. Muskiet, Ingrid M. Jazet, Borja Martinez‐Tellez, Patrick C. N. Rensen, Mariëtte R. Boon   +8 more
wiley   +1 more source

A DYRK inhibitor ameliorates glucose homeostasis and increases incretin-producing cells in diabetic mice. [PDF]

J Mol Endocrinol
Terasaki M, Zhou Q, Andersson O, Yamagishi SI.   +3 more
europepmc   +1 more source

Incretins modulate progesterone biosynthesis by regulating bone morphogenetic protein activity in rat granulosa cells.

Journal of Steroid Biochemistry and Molecular Biology, 2017
Yuki Nishiyama, Toru Hasegawa, S. Fujita, Nahoko Iwata, Satoko Nagao, T. Hosoya, K. Inagaki, J. Wada, F. Otsuka   +8 more
semanticscholar   +1 more source

Efficacy and Safety of Automated Insulin Delivery in People With Type 2 Diabetes: A Systematic Review and Meta‐Analysis

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 5091-5100, June 2026.
ABSTRACT Aims Studies evaluating automated insulin delivery (AID) in type 2 diabetes are limited in number and often conducted in small cohorts. We aimed to summarize efficacy and safety data through a systematic review and meta‐analysis. Materials and Methods We searched MEDLINE, PubMed, Web of Science, and CENTRAL databases and performed hand ...
Sergio Di Molfetta, Ludovico Di Gioia, Irene Caruso, Mariangela Caporusso, Sebastio Perrini, Annalisa Natalicchio, Luigi Laviola, Francesco Giorgino   +7 more
wiley   +1 more source

Incretin Mimetics as Potential Therapeutics for Concussion and Traumatic Brain Injury: A Narrative Review. [PDF]

Int J Mol Sci
Sipos S, Jerkic M, Rotstein OD, Schweizer TA.   +3 more
europepmc   +1 more source

Degradation of Incretins and Modulation of Blood Glucose Levels by Periodontopathic Bacterial Dipeptidyl Peptidase 4

Infection and Immunity, 2017
Y. Ohara-Nemoto, Manami Nakasato, Yu Shimoyama, T. T. Baba, T. Kobayakawa, T. Ono, T. Yaegashi, S. Kimura, T. Nemoto   +8 more
semanticscholar   +1 more source

Toward Personalized Medicine in Type 1 Diabetes: Understanding How Patient Heterogeneity Influences Therapeutic Efficacy

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4529-4545, June 2026.
ABSTRACT Pharmacologic interventions for type 1 diabetes (T1D) have advanced significantly in recent years with the advent of the first FDA approved therapy teplizumab for delaying symptomatic disease onset in 2022. Despite this progress, major hurdles remain in moving toward personalized medicine approaches for T1D.
Jasmine Pipella, Peter J. Thompson
wiley   +1 more source

Incretin mimetic [PDF]

, 2020
openaire   +1 more source